Shapetx Announces Adrian W. Briggs as Chief Technology Officer

ShapeTX announced the appointment of Adrian W. Briggs, Ph.D., as Chief Technology Officer (CTO). Previously, he led technology-focused teams at Bristol Myers Squibb, following the acquisition of AbVitro, where he pioneered high-throughput immune single-cell sequencing. As CTO, he will lead the Research Technologies division, focusing on innovation, refinement, and industrialization of technologies across ShapeTX’s platforms.

ShapeTX is a biotechnology company focused on developing innovative therapies for the treatment of various diseases.